Breast Cancer Risk of Birth Control Pills. A new study has revealed links between birth control pills and increased risks for developing breast cancer. The study found that working women who delay marriage and having children, and who are using contraceptive pills or undergoing what is described as “incidental” abortions also have … [Read more...]
Birth Control Pills Breast Cancer Risk
J&J Agrees to Settlement With Man Who Claims Taking Risperdal
Drug Risperdal Caused Grow Male Breasts Healthcare giant Johnson & Johnson has reached settlement terms with a man who claims that taking the company’s drug Risperdal as a child caused him to grow male breasts. According to a Bloomberg report, the case brought by Aron Banks was the first of at least 120 lawsuits making this … [Read more...]
Avastin Fails to Win Over FDA Panel
FDA Panel as Breast Cancer Treatment. For the second time in about a year, the Food & Drug Administration (FDA) oncology panel has voted to reject Avastin as a breast cancer treatment. The 6-0 vote was taken yesterday, at the conclusion of a contentious and emotional hearing in which the maker of Avastin tried to persuade the … [Read more...]
Pfizer Settles More Lawsuits
Pfizer Settles More Prempro, Premarin. Nearly 5,000 of the 10,000 breast cancer lawsuits Pfizer faced over its Prempro and Premarin hormone therapy drugs have been settled. According to a Bloomberg News report, Pfizer disclosed the Prempro and Premarin settlements in its latest 10Q report filed with the U.S. Securities and … [Read more...]
Prempro Doubles Breast Cancer Death Risk
Prempro Breast Cancer Death Risk. Prempro, already associated with a higher risk of breast cancer, has now been found to double the risk of death from the disease. Pfizer Inc.’s Prempro was once given to millions of women to treat the symptoms of menopause. Prempro is a combination of the hormones estrogen and progestin. In 2002, … [Read more...]
Avastin Breast Cancer Approval Decision
A decision on whether or not Avastin should be approved to treat breast cancer could come soon from the Food & Drug Administration (FDA). Avastin, is already approved to treat lung and colon cancer, but members of an FDA advisory committee voted 5-4 against approving Avastin for breast cancer treatment in December. However, … [Read more...]
Aranesp Study Shows Little Benefit for Breast Cancer Patients
Aranesp, an anemia drug, does not appear to benefit breast cancer patients. Amgen Inc., maker of Aranesp, recently said interim results from an independent study involving breast cancer patients found Aranesp did not enhance the effect of chemotherapy prior to surgery. The study involved over 700 patients and evaluated whether … [Read more...]
